Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
SOLV Stock Forecast 2025-2026
$66.07
Current Price
$11.68B
Market Cap
Buy 1
Hold 9
Sell 1
Wall St Analyst Ratings
Distance to SOLV Price Targets
+33.2%
To High Target of $88.00
+24.1%
To Median Target of $82.00
+7.5%
To Low Target of $71.00
SOLV Price Momentum
+3.3%
1 Week Change
-11.6%
1 Month Change
+2.5%
1 Year Change
+0.0%
Year-to-Date Change
-23.1%
From 52W High of $85.92
+40.1%
From 52W Low of $47.16
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Solventum (SOLV) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on SOLV and similar high-potential opportunities.
Latest SOLV Stock Price Targets & Analyst Predictions
Based on our analysis of 10 Wall Street analysts, SOLV has a neutral consensus with a median price target of $82.00 (ranging from $71.00 to $88.00). The overall analyst rating is Buy (6.2/10). Currently trading at $66.07, the median forecast implies a 24.1% upside. This outlook is supported by 1 Buy, 9 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by David Roman at Goldman Sachs, suggesting a 7.5% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
SOLV Analyst Ratings
1
Buy
9
Hold
1
Sell
SOLV Price Target Range
Low
$71.00
Average
$82.00
High
$88.00
Current: $66.07
Latest SOLV Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for SOLV.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 5, 2025 | Morgan Stanley | Patrick Wood | Equal-Weight | Maintains | $80.00 |
| Mar 3, 2025 | Goldman Sachs | David Roman | Sell | Maintains | $71.00 |
| Mar 3, 2025 | Mizuho | Steven Valiquette | Neutral | Maintains | $82.00 |
| Feb 28, 2025 | Piper Sandler | Jason Bednar | Neutral | Maintains | $84.00 |
| Feb 28, 2025 | Wells Fargo | Vik Chopra | Equal-Weight | Maintains | $75.00 |
| Feb 26, 2025 | B of A Securities | Travis Steed | Neutral | Maintains | $85.00 |
| Dec 4, 2024 | Mizuho | Steven Valiquette | Neutral | Initiates | $70.00 |
| Nov 11, 2024 | Morgan Stanley | Patrick Wood | Equal-Weight | Maintains | $73.00 |
| Nov 8, 2024 | Piper Sandler | Jason Bednar | Neutral | Maintains | $75.00 |
| Oct 8, 2024 | Stifel | Rick Wise | Buy | Initiates | $82.00 |
| Oct 7, 2024 | Piper Sandler | Jason Bednar | Neutral | Initiates | $71.00 |
| Sep 26, 2024 | Wolfe Research | Chris Senyek | Peer Perform | Initiates | $0.00 |
| Sep 5, 2024 | BTIG | Ryan Zimmerman | Neutral | Initiates | $0.00 |
| Aug 12, 2024 | Goldman Sachs | David Roman | Sell | Maintains | $54.00 |
| Aug 9, 2024 | Wells Fargo | Vik Chopra | Equal-Weight | Maintains | $64.00 |
| Jul 15, 2024 | Morgan Stanley | Patrick Wood | Equal-Weight | Maintains | $55.00 |
| Jul 10, 2024 | Goldman Sachs | David Roman | Sell | Maintains | $48.00 |
| Jun 25, 2024 | B of A Securities | Travis Steed | Neutral | Maintains | $60.00 |
| May 30, 2024 | Goldman Sachs | David Roman | Sell | Initiates | $54.00 |
| May 10, 2024 | B of A Securities | Travis Steed | Neutral | Initiates | $70.00 |
Solventum Corp (SOLV) Competitors
The following stocks are similar to Solventum based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
SOLV
Solventum Corp
mkt cap
11.68B
Solventum Corp (SOLV) Financial Data
Solventum Corp has a market capitalization of $11.68B with a P/E ratio of 23.9x. The company generates $8.25B in trailing twelve-month revenue with a 5.8% profit margin.
Revenue growth is +1.9% quarter-over-quarter, while maintaining an operating margin of +9.5% and return on equity of +6.6%.
Valuation Metrics
Market Cap
$11.68B
Enterprise Value
$18.85B
P/E Ratio
23.9x
PEG Ratio
11.9x
Price/Sales
1.4x
Growth & Margins
Revenue Growth (YoY)
+1.9%
Gross Margin
+53.9%
Operating Margin
+9.5%
Net Margin
+5.8%
EPS Growth
-88.6%
Financial Health
Cash/Price Ratio
+6.7%
Current Ratio
1.2x
Debt/Equity
276.5x
ROE
+6.6%
ROA
+4.8%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Solventum Corp (SOLV) Business Model
About Solventum Corp
What They Do
Produces advanced solvent solutions for industries.
Business Model
The company generates revenue through the production and distribution of high-quality, eco-friendly solvent solutions used in various sectors, such as pharmaceuticals, chemicals, and manufacturing. By catering to both large multinational corporations and smaller enterprises, Solventum Corp ensures a broad market reach and diversified customer base.
Additional Information
Headquartered in a hub of industrial innovation, Solventum Corp emphasizes research and development to enhance its offerings and comply with international environmental standards. Its commitment to sustainability and collaboration with industry leaders positions it as a key player in promoting eco-conscious practices within the industrial supply chain.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
22,000
CEO
Mr. Bryan C. Hanson
Country
United States
IPO Year
2024
Website
www.solventum.comSolventum Corp (SOLV) Latest News & Analysis
Latest News
Quick Summary
Solventum (NYSE: SOLV) will announce its Q1 fiscal 2025 financial results on May 8, 2025, after U.S. market close.
Why It Matters
Solventum's upcoming Q1 financial results could impact stock performance, influencing investor sentiment and market expectations for the company's future growth and profitability.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Solventum (SOLV) has a strong history of earnings surprises and is positioned well for a potential positive outcome in its upcoming quarterly report.
Why It Matters
Solventum's strong earnings surprise history and positive indicators suggest potential for exceeding expectations in the upcoming report, which could drive stock price appreciation.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Solventum (SOLV) experienced significant trading volume recently. However, recent earnings estimate revisions may hinder its upward momentum in the near term.
Why It Matters
Increased trading volume indicates heightened interest in Solventum (SOLV), but negative earnings estimate revisions may signal potential price declines ahead.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
SOLV partners with SprintRay to launch a solution for same-day dental restorations, improving efficiency and patient care in digital dentistry.
Why It Matters
The partnership between SOLV and SprintRay enhances efficiency in dental restorations, potentially increasing market demand and growth in the dental technology sector, impacting investor sentiment positively.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Solventum, formerly 3M Health Care, partners to enhance its Dental Solutions by focusing on durable same-day restoratives using 3D printing and innovative materials to improve efficiency.
Why It Matters
Solventum's partnership signals innovation in dental solutions, potentially boosting market share and profitability through advanced technology, appealing to investors in the healthcare sector.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Solventum (SOLV) held its 2025 Investor Day, detailing strategic priorities, business segments, and a long-range plan aimed at growth and value creation.
Why It Matters
Solventum's 2025 Investor Day reveals strategic priorities and growth plans, signaling potential future performance and value creation, which can influence investor sentiment and stock valuation.
Source: Benzinga
Market Sentiment:
Positive
Frequently Asked Questions About SOLV Stock
What is Solventum Corp's (SOLV) stock forecast for 2025?
Based on our analysis of 10 Wall Street analysts, Solventum Corp (SOLV) has a median price target of $82.00. The highest price target is $88.00 and the lowest is $71.00.
Is SOLV stock a good investment in 2025?
According to current analyst ratings, SOLV has 1 Buy ratings, 9 Hold ratings, and 1 Sell ratings. The stock is currently trading at $66.07. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for SOLV stock?
Wall Street analysts predict SOLV stock could reach $82.00 in the next 12 months. This represents a 24.1% increase from the current price of $66.07. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Solventum Corp's business model?
The company generates revenue through the production and distribution of high-quality, eco-friendly solvent solutions used in various sectors, such as pharmaceuticals, chemicals, and manufacturing. By catering to both large multinational corporations and smaller enterprises, Solventum Corp ensures a broad market reach and diversified customer base.
What is the highest forecasted price for SOLV Solventum Corp?
The highest price target for SOLV is $88.00 from at , which represents a 33.2% increase from the current price of $66.07.
What is the lowest forecasted price for SOLV Solventum Corp?
The lowest price target for SOLV is $71.00 from David Roman at Goldman Sachs, which represents a 7.5% increase from the current price of $66.07.
What is the overall SOLV consensus from analysts for Solventum Corp?
The overall analyst consensus for SOLV is neutral. Out of 10 Wall Street analysts, 1 rate it as Buy, 9 as Hold, and 1 as Sell, with a median price target of $82.00.
How accurate are SOLV stock price projections?
Stock price projections, including those for Solventum Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 28, 2025 9:13 PM UTC